XM does not provide services to residents of the United States of America.

Indian shares surrender early gains as financials offset rise in IT, pharma



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares surrender early gains as financials offset rise in IT, pharma</title></head><body>

Updates at 10:34 a.m. IST

By Bharath Rajeswaran

BENGALURU, Sept 10 (Reuters) -Indian shares were largely flat on Tuesday, erasing their openinggains, as a drop in life insurance stocks on worries of slowing growth momentum weighed on high-weightage financials and offset a rise in IT andpharma stocks.

The Nifty 50 index .NSEI was up 0.02% at 24,942.55 points, while the S&P BSE Sensex .BSESN was little changed at 81,611.77, as of 10:34 a.m. IST.

Both the benchmark indexes roseabout 0.25% in early trade before surrendering gains, weighed down byfinancials .NIFTYFIN, which lost 0.5%.

Life insurers HDFC Life HDFL.NS and SBI Life SBIL.NS lost 2.5% each, after posting modest growth in premiums for August.

"Growth slowdown was sharper for large insurers compared to small insurers while growth in the number of policies sold also moderated in August," said analysts at HSBC Securities and Capital Markets (India).

The drop in financials offset a 0.7%rise in theinformation technology index .NIFTYIT.

Pharma stocks .NIPHARM gained 1% after India's goods and services tax (GST) council recommended a reduction in tax rates on specific cancer drugs.

Meanwhile, theU.S. consumer price index, due on Wednesday, is expected to show that inflation remains on the path back to the Federal Reserve's target and play a crucial part in deciding thesize of a likely ratecut next week.

U.S. inflation and jobless claims data willbe pivotal in determining the market'sdirection, Centrum Institutional Research said, adding that the domestic market is currently navigating a delicate balance between potential rate cuts and U.S. recession apprehensions.

Among individual stocks, snackmakers like Gopal Snacks GOPA.NS, Prataap Snacks PRAT.NS and Bikaji Foods BIKA.NS rose about 4% each after the GST council recommended cutting the taxrate on Indian savory snacks to 12% from 18%.

The more domestically focussed small- .NIFSMCP100 and mid-caps .NIFMDCP100 rose about 1% each.




Reporting by Bharath Rajeswaran in Bengaluru; Editing by Rashmi Aich and Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.